Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
about
Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Oral Mucositis: Melatonin Gel an Effective New Treatment.Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 TrialEvaluation of a moisturising micro-gel spray for prevention of cell dryness in oral mucosal cells: an in vitro study and evaluation in a clinical settingParadoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells.Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects.Topical application of hPDGF-A-modified porcine BMSC and keratinocytes loaded on acellular HAM promotes the healing of combined radiation-wound skin injury in minipigs.Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial.Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation.
P2860
Q33632748-69F0528E-11C5-4AC6-9343-7EA57A8127CEQ33650357-1B412FA2-89FD-4486-8081-FB41422E44E2Q33755115-81F79BAA-AD75-4CF0-A7F2-94F4F2D5CB17Q36237979-05266928-3C46-43C8-B8F1-E3302F00FDF3Q36498700-6A593D03-41CF-4A64-8D23-C7A502B5743FQ37706156-6C141EAA-2673-468D-8869-B5D3B99F9DB5Q38044278-170AA39E-19F1-41E5-91B4-01CE65F11FE1Q38410471-8CEA5976-282E-42C1-BB8F-26F2E3D3EE41Q44455115-7D2FA43A-F5B8-4CFD-9C42-34BA0497FF7BQ50224646-8E09B4DC-C013-4864-A894-CD4F4904366FQ50785469-D303D3CF-9C3E-49A1-8786-FAF8EE9F5DD4
P2860
Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recombinant human epidermal gr ...... th head and neck malignancies.
@en
Recombinant human epidermal gr ...... th head and neck malignancies.
@nl
type
label
Recombinant human epidermal gr ...... th head and neck malignancies.
@en
Recombinant human epidermal gr ...... th head and neck malignancies.
@nl
prefLabel
Recombinant human epidermal gr ...... th head and neck malignancies.
@en
Recombinant human epidermal gr ...... th head and neck malignancies.
@nl
P2093
P2860
P1476
Recombinant human epidermal gr ...... th head and neck malignancies.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2354.2008.00971.X
P407
P577
2009-04-23T00:00:00Z